Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Pediatr Pulmonol. 2022 Dec 9;58(3):825–833. doi: 10.1002/ppul.26261

Table 3:

Comparison of cytokine levels between controls without CF (n=20) and pwCF (n=48) at baseline, and between pwCF at baseline and 6-months post-ETI

Control (at baseline) pwCF (at baseline) pwCF 6-months post-ETI Control vs pwCF at baseline1 pwCF at baseline vs. 6-months post-ETI2
Mean (pg/mL)±SD p p
IL-22 0.2 ±0.2 0.7 ±0.2 0.4 ±0.3 0.097 0.256
IL-23 0.9 ±0.7 1.8 ±3.9 2.1 ±5.8 0.167 0.595
IFN-γ 3.7 ±2.4 4.7 ±5.7 4.9 ±4.8 0.283 0.838
IL-4 0.04 ±0.02 0.1 ±0.3 0.1 ±0.2 0.186 0.465
IL-6 0.4 ±0.2 1.2 ±1.3 0.6 ±0.9 <0.001* 0.002*
IL-8 2.1 ±0.9 3.8 ±3.1 2.6 ±1.8 0.001* 0.004*
IL-10 0.2 ±0.2 2.1 ±6.7 2.5 ±8.4 0.056 0.214
IL-13 2.3 ±1.2 1.2 ±1.3 1.2 ±1.4 0.001* 0.688
IL-17A 0.6 ±0.2 1.8 ±1.3 1.3 ±1.0 <0.001* 0.004*
1

independent t-test,

2

paired t-test

*

p ≤ 0.05